Humoral and Cellular Immunogenicity and Safety of 3-Dose Inactivated COVID-19 Vaccine in Young Children Less Than 5 Years With Kidney Diseases
Kidney Int Rep
.
2023 Aug 19;8(10):2177-2179.
doi: 10.1016/j.ekir.2023.08.012.
eCollection 2023 Oct.
Authors
Eugene Yu-Hin Chan
1
,
Daniel Leung
2
,
Samuel M S Cheng
3
,
Jaime S Rosa Duque
2
,
Xiaofeng Mu
2
,
Fanny Tsz-Wai Ho
1
,
Pak-Chiu Tong
1
,
Wai-Ming Lai
1
,
Matthew H L Lee
4
,
Stella Chim
4
,
Issan Y S Tam
2
,
Leo C H Tsang
3
,
Kelvin K H Kwan
3
,
Yuet Chung
2
,
Howard H W Wong
2
,
Amos M T Lee
2
,
Wing Yan Li
2
,
Summer T K Sze
2
,
Jennifer H Y Lam
2
,
Derek H L Lee
2
,
Sau Man Chan
2
,
Wenwei Tu
2
,
Malik Peiris
3
5
,
Alison Lap-Tak Ma
1
,
Yu Lung Lau
2
Affiliations
1
Pediatric Nephrology Centre, Department of Pediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Kowloon City, Hong Kong, China.
2
Department of Pediatrics and Adolescent Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong, China.
3
School of Public Health, The University of Hong Kong, Pok Fu Lam, Hong Kong, China.
4
Department of Pediatrics and Adolescent Medicine, Queen Mary Hospital, Pok Fu Lam, Hong Kong, China.
5
Centre for Immunology and Infection C2i, Shatin, Hong Kong, China.
PMID:
37850008
PMCID:
PMC10577489
DOI:
10.1016/j.ekir.2023.08.012
No abstract available